Objective: Aprotinin, a non-specific serine protease inhibitor, reduces postoperative bleeding after coronary artery surgery. The mechanism of action for this 'blood-sparing' effect of aprotinin is only partially clarified. We therefore aimed to investigate the effect of aprotinin on the release of nitric oxide (NO), a vasodilator and antiaggregant factor, from rat coronary microvascular endothelial cells and on the NO-mediated endothelium-dependent relaxation of rat thoracic aorta. Methods: Endothelium-intact and endothelium-denuded thoracic aortic rings from Wistar rats (250-300 g) were suspended in organ chambers. Contractile and relaxant responses in the absence and presence of aprotinin (125, 250 and 500 KIU / ml) were recorded via a mechanotransducer. Coronary microvascular endothelial cells (CMEC) were isolated on a Langendorff system by collagenase perfusion of the hearts from the same rats. Calcium ionophore-(1 mM) induced release of NO from confluent cells was determined spectrophotometrically by measuring its stable metabolites, nitrite and nitrate, via Griess reaction. Results: Aprotinin selectively enhanced phenylephrine-induced contractions in endothelium-intact rat thoracic aortic rings, but not in the endothelium-denuded rings. The use of a nitric oxide synthesis inhibitor Nv-nitro-L-arginine methyl ester (100 mM) on endothelium-intact rings produced a similar increase in phenylephrine-induced contractions. KCl-induced contractions remained unaltered. Aprotinin inhibited acetylcholine-, calcium ionophore-and L-arginine-induced endothelium-dependent relaxations, but not sodium nitroprusside-induced endothelium-independent relaxation. Aprotinin had no significant effect on basal nitrite-nitrate release from CMEC, while it inhibited calcium ionophore-induced total nitrite accumulation in the supernatants. Conclusion: Aprotinin selectively impairs endothelium-dependent relaxation as well as basal NO availability in rat thoracic aortic rings and inhibits NO release from rat CMEC. This effect of the drug may contribute to its 'blood-sparing' action and may also account for the increase in perioperative restenosis risk observed in clinical practice during aprotinin therapy.
Introduction
trials with aprotinin has shown that the drug decreases mortality, the need for rethoracotomy and the proportion of Aprotinin, a non-specific serine protease inhibitor, is patients requiring blood transfusion [2] . Although the currently used to reduce blood loss and blood need for efficacy of aprotinin as a haemostatic agent is indisputable, transfusion after cardiac operations requiring cardiopulits safety has been a matter of debate. Indeed, it has been monary bypass [1] . The mechanism of action for the reported that aprotinin might increase the risk of graft observed 'blood-sparing' effect of aprotinin has only been thrombosis and subsequently the incidence of perioperative partially clarified. Recently, a meta-analysis of clinical myocardial infarction [3] . There have been some experimental observations suggesting that aprotinin may increase tendency to thrombosis in vitro. Indeed, it has *Corresponding author. Tel.: 190-232-388-2862; fax: 190-232-342-been shown that aprotinin alters the ratio of 6-keto-prosta-2142.
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von Willebrand factor in cultured human umbilical vein for CMEC isolation, while the thoracic aortas of the same endothelial cells, leading to increased platelet aggregation animals were used for vascular reactivity experiments. with a tendency to plug particularly the small vessels [4, 5] . The implication of these in vitro studies is that periopera-2.1. Vascular reactivity studies tive infarction during aprotinin treatment may occur not only through thrombosis of the bypass graft but also
The aorta was cut into four 3-4-mm wide rings. In some through thrombotic occlusion of poorly perfused areas of rings, the endothelium was removed mechanically by coronary microcirculation.
inserting a small forceps into the lumen and gently rolling.
Endothelial cells play an important role in the regulation
In each experiment, endothelium-intact and endotheliumof normal microcirculation by releasing several vasoactive denuded rings (two of each) were suspended horizontally factors including nitric oxide (NO). NO is generated by the under a resting tension of 2.0 g in 30-ml organ chambers enzymatic activities of a group of enzymes called NO containing Krebs solution of the following composition in synthases (NOSs). Three main isoforms of NOS have so mM; NaCl, 118.30; KCl, 4.70; MgSO , 1.20; KH PO , 4 2 4 far been described; the constitutive isoforms NOS-I and 1.22; CaCl , 2.50; NaHCO , 25.00; glucose, 11.10 (pH 7.4 2 3 NOS-III, and the inducible isoform NOS-II (for a recent at 378C, gassed with carbogen). Each ring was connected review, see Ref. [6] ). It has been suggested that the to a force displacement transducer for the measurement of production of NO is significantly increased during and isometric force, which was continuously displayed and after cardiopulmonary bypass [7] . The systemic endotoxrecorded on-line on a computer via an eight-channel aemia that occurs with the institution of cardiopulmonary transducer data acquisition system. bypass is a potent stimulus for the release of proinflammatAfter initial equilibration period of 60-90 min, ordinary ory cytokines, which induces NOS-II expression and
Krebs solution was replaced with fresh Krebs solution subsequent NO release [8] . It has been reported that containing 1 mM indomethacin to exclude relaxant effects aprotinin reduced NO production in vivo in the airways of that may be generated by prostanoids. All experiments patients undergoing cardiopulmonary bypass and decreased were performed in the latter solution. cytokine-induced NOS-II expression in a dose-dependent Endothelium-denuded rings were used to assess the manner in vitro in cultures of a murine epithelial cell line contractile responses. The absence of endothelium was [9, 10] . However, several other drugs which are commonly confirmed by the absence of relaxations to acetylcholine used for reducing blood requirement after cardiopulmonary (ACh) (1 mM) in rings precontracted with a submaximal bypass, such as tranexamic acid and e-aminocaproic acid, concentration of phenylephrine (PE) (0.3-1 mM). Contracdid not attenuate cytokine-induced NO production in the tile responses were generated by addition of either insame cell line [11, 12] . This effect was therefore selectively cremental concentrations of PE (0.003-30 mM) or a single attributed to aprotinin.
concentration of KCl (40 mM). The Krebs solution Although the inhibitory effect of aprotinin on the release contained 40 mM KCl, and was prepared by the equimolar of inducible NO has been reported by several investigators, replacement of NaCl by KCl. the number of reports demonstrating its effect on the Endothelium-intact rings were used for assessing endoproduction of constitutive NO is rather limited. A recent thelium-dependent and endothelium-independent relaxant report has shown that aprotinin inhibits both NOS-I and responses. The rings were precontracted with PE (0.3-1 NOS-II in whole rat brain homogenates; hence it is mM) and relaxations to ACh (0.003-30 mM), calcium accepted as the 'first competitive protein inhibitor of NOS ionophore A23187 (A23187) (0.003-3 mM), L-arginine activity' [13] . The goal of this study was therefore to (0.3-1000 mM), D-arginine (0.3-1000 mM) or sodium investigate the potential effects of aprotinin on the in vitro nitroprusside (SNP) (0.001-3 mM) were studied. KCl (40 release of constitutive NO in aortic rings and coronary mM) depolarization was also recorded on the endotheliummicrovascular endothelial cells (CMEC) isolated from intact rings. healthy rats by vascular reactivity experiments and Griess Both the endothelium-intact and endothelium-denuded reaction, respectively. rings were incubated with three different concentrations of aprotinin (125, 250 and 500 KIU / ml) for 15 min. The aprotinin used in this study was the commercially available ® 2. Methods form of the drug (Trasylol , Bayer) which contained 1.4 mg / ml (10 000 KIU / ml) of the active compound in sterile The investigation conforms with the Guide for the Care 0.9% NaCl. To ensure that vasomotor responses obtained and Use of Laboratory Animals published by the US were not a direct consequence of NaCl overloading, the National Institutes of Health (NIH Publication No. 85-23, concentration of NaCl was increased in control rings to the revised 1996) and was approved by the Animal Ethics same levels of those incubated with aprotinin. Hence, the Committee of Ege University, Izmir, Turkey. Hearts and final approximate concentrations of NaCl corresponding thoracic aortas of male Wistar rats (250-300 g) were 125, 250 and 500 KIU / ml aprotinin application were excised under light ether anaesthesia. The hearts were used 0.011, 0.023 and 0.045%, respectively. Finally, in a series of experiments, PE concentrationsupernatant from each flask was collected after the incubaresponse curves were generated in endothelium-intact rings tion period and centrifuged to remove cells and particles. in response to successive incubation with NaCl, aprotinin
Nitrate was reduced to nitrite by equilibrating 100 ml of alone and aprotinin plus Nv-nitro-L-arginine methyl ester samples (supernatants and standards) in sodium phosphate (L-NAME) (100 mM) to inhibit NOS-III activity.
buffer (pH 7.5) containing FAD (0.02 mM), NADPH (0.5 mM) and nitrate reductase (0.1 U / ml) in a final volume of 2.2. Cell culture 510 ml at room temperature for 90 min. Sodium nitrate (2-50 mM) dissolved in Krebs-HEPES solution was used CMEC were isolated as previously described [14] .
as the standard. Total nitrite was then determined spectroBriefly, the hearts were mounted and perfused retrogradely photometrically using the Griess reaction. The amount of on a constant-flow Langendorff system with 0.04% coltotal nitrite in each sample was calculated by linear lagenase. The ventricles were chopped and collagenase regression using the absorbance of the sodium nitrate digestion was quenched by the addition of bovine serum standards each day. The amount of total cellular protein in albumin to the perfusate. CMEC were obtained by sedithe respective flasks was determined by Lowry's method mentation of myocytes and incubated in 0.01% trypsin at after lysis with a buffer containing SDS 0.1% in 10 mM 378C for the prevention of non-endothelial cell attachment.
Tris, pH 7.4 [16] . Total nitrite accumulated in each flask Cells were then activated by washing in calcium and was defined as mM per mg of protein in the corresponding suspended in Medium 199 supplemented with L-glutamine, flask. fetal calf serum and antibiotic / antifungal agents. Cell suspensions were plated and incubated at 378C under 5% 2.4. Drugs CO . After 1-h incubation, unattached cells were washed 2 ® off with saline and remaining cells were cultured to Aprotinin (Trasylol ) was a generous gift of Bayer confluence. Cultured cells formed confluent monolayers (Turkey). The following drugs were from Sigma (USA): with typical 'cobblestone' morphology within 5-7 days.
PE, ACh, A23187, L-arginine, D-arginine, SNP, inFor further culture, cells were trypsinized and subcultured.
domethacin, collagenase, trypsin, bovine serum albumin, Cells have previously been characterised as endothelial and sodium nitrate. KCl was from Merck (Germany). All by the uptake of fluorescently labelled acetylated LDL cell culture materials were from Gibco BRL (Life Tech- [14] . The endothelial cells obtained using this method may nologies, UK). include some endocardial endothelial cells, as well as some endothelial cells from larger coronary vessels. However, 2.5. Statistical analysis the statistical average (more than 90%) represents predominantly microvascular endothelial cells since the vast Results were expressed as mean6S.E.M. n numbers majority of cardiac endothelial cells are found in small given throughout the paper denote the number of aortic vessels and capillary bed. Therefore, the number of rings isolated from different rats in vascular reactivity endocardial endothelial cells would be negligible studies and the number of flasks used in cell culture (0.0002%) [14] .
studies. Concentration-response curves were fitted by nonCells between passages 3 and 5 were used in the study.
linear regression with simplex algorithm, and E and max On the day of study, the cells were washed with KrebspD (2log EC ) values were calculated using the soft- (pH 7.4). Some of the cells were then incubated with precontraction. Comparisons of concentration-response A23187 (1 mM) for 1 h at 378C in Krebs solution to curves were evaluated by two-way analysis of variance stimulate NO release, while others were left untreated to (ANOVA) for repeated measures. The differences between serve as controls to determine basal NO release. To the means of total nitrite levels and tension developed to investigate the effect of aprotinin on NO release, CMEC KCl were analysed by one-way ANOVA, as well as the were treated with aprotinin (125, 250 and 500 KIU / ml) for means of E and pD values. Vasoconstrictor responses NO release from cultured CMEC was determined by measuring the accumulation of its stable degradation PE induced a concentration-dependent contraction in products, nitrite and nitrate. Nitrate was detected after both endothelium-intact and endothelium-denuded rings. reduction to nitrite using nitrate reductase [15] . Briefly, the
The maximum contractile response (E ) and sensitivity max Table 2 shows the results of contractile responses to KCl 500 KIU / ml) did not change their basal tensions (data not depolarization (40 mM) in aprotinin-treated and correshown), nor did it affect PE response in endotheliumsponding NaCl-treated rings. The contractile response denuded rings. However, in endothelium-intact rings, all generated by KCl was significantly higher in all endoconcentrations of aprotinin significantly increased E thelium-denuded rings compared to the endothelium-intact max without changing pD values (P,0.05, Table 1 ). When 2 endothelium-intact rings were incubated with L-NAME in Table 2 Effect of aprotinin (125, 250 and 500 KIU / ml) on the tension (mg) the presence of aprotinin, the contractile response to PE developed to KCl (40 mM) in endothelium-intact and endotheliumwas significantly increased only in rings incubated with a denuded rat aortic rings 125 KIU / ml aprotinin (P,0.05, Fig. 1A ). There were no Endothelium-intact Endothelium-denuded statistically significant differences in PE contractility be- L-NAME (Fig. 1B,C) observed ( Fig. 1, P rings (P,0.05 and P,0.01) other than 250 KIU / ml aprotinin group. The comparison of aprotinin-treated groups with corresponding NaCl-treated groups did not reveal any significant difference in KCl contractility.
Vasodilator responses
Endothelium-intact rings precontracted with PE gave a concentration-dependent relaxant response to ACh (Fig.  2A), A23187 (Fig. 2B) , L-arginine (Fig. 2C ) and sodium nitroprusside, but not to D-arginine (data not shown). Aprotinin significantly decreased endothelium-dependent relaxations to ACh, A23187 and L-arginine at all concentrations studied (P,0.001, Fig. 2 ) with a significant decrease in pD values (P,0.05 and P,0.001, Table 3 for aprotinin 125, 250 and 500 KIU / ml, respectively; see Table 3 for pD values). 
Nitrite levels
Total nitrite accumulation in cultured CMEC is shown in Fig. 3 . A23187 (1 mM) induced a significant nitrite accumulation in these cells (195.9618.6 mM / mg protein), which was approximately two times the basal value (115.564.1 mM / mg protein) (P,0.001). Incubation of the cells with aprotinin (125, 250 and 500 KIU / ml) did not significantly change basal nitrite accumulation. However, it significantly inhibited A23187-induced accumulation of nitrite at all concentrations studied (P,0.01 and P, 0.001).
Discussion
The results of the present investigation show that incubation of rat thoracic aortic rings with aprotinin, a serine protease inhibitor, resulted in an impairment of endothelial function. The observation that aprotinin enhanced PE-induced contractility in endothelium-intact rings, but not in the endothelium-denuded rings, suggests a prominent effect of the drug on endothelial cells, particularly on the synthesis and / or release of endotheliumderived relaxant factors (EDRFs). It has previously been demonstrated in rat aortas that the removal of endothelium augments contractions induced by alpha-adrenergic agonists and spontaneous release of EDRF is a functional antagonist of these contractions [17] . Thus, the significant and 500 KIU / ml (squares) on the endothelium-dependent relaxation of rat increase in PE contractility in endothelium-intact rings aorta induced by acetylcholine (A, ACh), calcium ionophore (B, A23187) after aprotinin incubation suggests not a mechanical, but a pharmacologically using a NOS-III inhibitor, L-NAME, in been reported that isometric contraction of rabbit aorta 21 endothelium-intact rings. The rings incubated with apactivates NOS-III and this activation involves a Carotinin in the presence and absence of L-NAME did not independent, tyrosine kinase inhibitor-sensitive pathway reveal any difference in the contractile response to PE at [18] . Absence of the possible expected effect of aprotinin higher concentrations (250 and 500 KIU / ml), but yielded on KCl-induced contractions may perhaps be explained by 21 a significant difference at 125 KIU / ml, suggesting a the lack of interference of the drug with the Ca -inconcentration-dependent inhibitory effect of aprotinin on dependent activation of NOS-III. However, this interpreta-NO release.
tion remains speculative and requires more detailed On the other hand, isometric contractions induced by studies. KCl in endothelium-intact and endothelium-denuded rings EDRF release by ACh is a muscarinic-receptor operated remained similar after aprotinin incubation. It has recently effect, while A23187 works in a receptor-independent manner and both agents stimulate an increase in intracellular calcium content in the endothelial cells, which subsequently activates NOS-III [19] . This study was dealing with non-prostanoid EDRF, possibly NO, since prostanoid response was excluded by the incubation of aortic rings with indomethacin throughout the experiments. The decrease in both ACh-and A23187-induced relaxation of aortic rings after aprotinin incubation indicates that postreceptor events rather than receptor-operation in endothelial cells were involved in the impaired NO response. To address the question that aprotinin may interfere with the substrate availability or consumption, L-arginine-induced relaxations were also recorded. It was observed that the drug impaired relaxant responses to the substrate L-arginine as well, an observation suggesting that the function of NOS-III is impaired. Finally, the integrity of vascular smooth muscle in terms of relaxant function was tested using an endothelium-independent relaxant agent, sodium nitroprusside. Since sodium nitroprusside evoked similar concentration-relaxation curves in control rings and in the rings incubated with aprotinin, the possibility that aprotinin might inhibit cGMP effector cascade is unlikely. Aprotinin has also been known to inhibit kallikrein, the enzyme necessary for the synthesis of bradykinin which is another endothelium-dependent NO generator. Inhibition of the activity of the bradykinin-generating protease (kal- The findings in vascular rings indirectly represent the subtypes may be explained by the difference in the source effect of aprotinin on macrovascular endothelial cells.
of the tissue used in these in vitro studies. However, the likely effect of the drug on the endothelial
The results of our study reveal an in vitro inhibitory cells of microcirculation also requires investigation; if effect of aprotinin on the release of NO from endothelial aprotinin impaired NO-mediated responses in myocardial cells. A compound having such an effect is expected to microcirculation, the outcome of this effect would be more increase arterial pressure when given in vivo. However, it dramatic. Therefore, experiments based on the direct has been reported that infusion of aprotinin in doses up to measurement of stable NO metabolites, namely nitrite and 7000 KIU / ml failed to affect mean arterial pressure and nitrate, in cultured CMEC were performed to confirm the carotid blood flow or hindlimb / pulmonary vascular resistdata obtained from vascular reactivity experiments. Apance in rat [24] . Therefore, additional studies investigating rotinin did not change the basal release of NO in these possible in vivo and in vitro effects of aprotinin on cells; however, A23187-stimulated release of NO was different vascular beds should be carried out. inhibited. Therefore, it may be suggested that the inhibition
In conclusion, aprotinin was found to impair NO-me- 21 is limited to Ca -dependent activation of NOS-III. Posdiated endothelium-dependent relaxation in rat thoracic sible factors such as a decrease in the enzymatic activity of aortic rings and inhibit NO release from cultured CMEC NOS-III or an inhibition in NOS-III gene expression may isolated from rat hearts. Since NO is a native endotheliumbe proposed to account for this impairment. It has previderived inhibitor of platelet aggregation, this effect of ously been reported that some protease inhibitors of the aprotinin may contribute to its 'blood-sparing' action. chloromethylketone group prevent expression of NOS-II in However, impairment of endothelial function and excesvascular smooth muscle cells by blocking the activation of sive inhibition of constitutive NO release from endothelial nuclear factor kB (NFkB) [20] . Consistent with this cells may result in substantial formation of thrombosis. concept, the promoter region of the NOS-III gene also Therefore, aprotinin-induced impairment in endothelial contains a nuclear factor-1 (NF-1)-like binding site [21] . function may also be responsible for the increase in Therefore it is likely that inhibition of NOS-III expression perioperative restenosis risk observed in clinical practice by aprotinin, a protease inhibitor with pharmacologic during aprotinin therapy. properties similar to chloromethylketones, may probably result from the blockade of this region. The exact mechanism of action of aprotinin remains to be determined
